Stockreport

AEON Biopharma Provides Update on Development Pipeline

AEON Biopharma, Inc. Class A  (AEON) 
PDF IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on dev [Read more]